These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 23091201)

  • 1. Drug-induced arrhythmia: pharmacogenomic prescribing?
    Behr ER; Roden D
    Eur Heart J; 2013 Jan; 34(2):89-95. PubMed ID: 23091201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding drug-induced torsades de pointes: a genetic stance.
    Kannankeril PJ
    Expert Opin Drug Saf; 2008 May; 7(3):231-9. PubMed ID: 18462182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genetics of pro-arrhythmic adverse drug reactions.
    Petropoulou E; Jamshidi Y; Behr ER
    Br J Clin Pharmacol; 2014 Apr; 77(4):618-25. PubMed ID: 23834499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular drugs inducing QT prolongation: facts and evidence.
    Taira CA; Opezzo JA; Mayer MA; Höcht C
    Curr Drug Saf; 2010 Jan; 5(1):65-72. PubMed ID: 20210721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding torsade de pointes: a bridge to tailored drug therapy?
    Tan HL; Wilde AA
    Cardiovasc Drugs Ther; 2002 Mar; 16(2):87-8. PubMed ID: 12090899
    [No Abstract]   [Full Text] [Related]  

  • 6. Dofetilide-induced long QT and torsades de pointes.
    Aktas MK; Shah AH; Akiyama T
    Ann Noninvasive Electrocardiol; 2007 Jul; 12(3):197-202. PubMed ID: 17617063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dangerous and life-threatening drugs - practical lessons from the long QT syndrome.
    Schutte D; Obel W
    Cardiovasc J S Afr; 2002; 13(2):54-61. PubMed ID: 11981581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case ascertainment and estimated incidence of drug-induced long-QT syndrome: study in Southwest France.
    Molokhia M; Pathak A; Lapeyre-Mestre M; Caturla L; Montastruc JL; ; McKeigue P
    Br J Clin Pharmacol; 2008 Sep; 66(3):386-95. PubMed ID: 18637888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome wide analysis of drug-induced torsades de pointes: lack of common variants with large effect sizes.
    Behr ER; Ritchie MD; Tanaka T; Kääb S; Crawford DC; Nicoletti P; Floratos A; Sinner MF; Kannankeril PJ; Wilde AA; Bezzina CR; Schulze-Bahr E; Zumhagen S; Guicheney P; Bishopric NH; Marshall V; Shakir S; Dalageorgou C; Bevan S; Jamshidi Y; Bastiaenen R; Myerburg RJ; Schott JJ; Camm AJ; Steinbeck G; Norris K; Altman RB; Tatonetti NP; Jeffery S; Kubo M; Nakamura Y; Shen Y; George AL; Roden DM
    PLoS One; 2013; 8(11):e78511. PubMed ID: 24223155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac safety, drug-induced QT prolongation and torsade de pointes (TdP).
    Ritter JM
    Br J Clin Pharmacol; 2012 Mar; 73(3):331-4. PubMed ID: 22329611
    [No Abstract]   [Full Text] [Related]  

  • 11. Common variation in the NOS1AP gene is associated with drug-induced QT prolongation and ventricular arrhythmia.
    Jamshidi Y; Nolte IM; Dalageorgou C; Zheng D; Johnson T; Bastiaenen R; Ruddy S; Talbott D; Norris KJ; Snieder H; George AL; Marshall V; Shakir S; Kannankeril PJ; Munroe PB; Camm AJ; Jeffery S; Roden DM; Behr ER
    J Am Coll Cardiol; 2012 Aug; 60(9):841-50. PubMed ID: 22682551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic basis of drug-induced arrhythmias.
    Vos MA; Paulussen AD
    Ann Med; 2004; 36 Suppl 1():35-40. PubMed ID: 15176422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular basis of drug-induced torsades de pointes.
    Roden DM
    Br J Pharmacol; 2008 Aug; 154(7):1502-7. PubMed ID: 18552874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QT interval and drug therapy.
    Drug Ther Bull; 2016 Mar; 54(3):33-6. PubMed ID: 26966121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugs that cause Torsades de pointes and increase the risk of sudden cardiac death.
    Wolbrette DL
    Curr Cardiol Rep; 2004 Sep; 6(5):379-84. PubMed ID: 15306095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Torsades de pointes with a severely prolonged QT interval induced by an initial low dose sotalol intake.
    Yalta K; Turgut O; Yilmaz A; Yilmaz MB; Kendirlioglu O; Karadas F
    Int J Cardiol; 2007 Apr; 116(3):e95-7. PubMed ID: 17126428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes.
    Yang P; Kanki H; Drolet B; Yang T; Wei J; Viswanathan PC; Hohnloser SH; Shimizu W; Schwartz PJ; Stanton M; Murray KT; Norris K; George AL; Roden DM
    Circulation; 2002 Apr; 105(16):1943-8. PubMed ID: 11997281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced changes in the T-wave morphology.
    Malik M
    Drug Saf; 2009; 32(7):613-7. PubMed ID: 19530747
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug induced QT prolongation].
    Altmann D; Eggmann U; Ammann P
    Wien Klin Wochenschr; 2008; 120(5-6):128-35. PubMed ID: 18365152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-QT caused by drugs and torsade de pointes: a genetic basis?].
    Schwartz PJ
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 1):277-9. PubMed ID: 12497921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.